Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer Meeting Abstract


Authors: Hong, D. S.; Shen, L.; van Tilburg, C. M.; Tan, D. S. W.; Kummar, S.; Lin, J. J.; Doz, F. P.; McDermott, R. S.; Albert, C. M.; Berlin, J.; Bielack, S. S.; Lassen, U. N.; Tahara, M.; Norenberg, R.; Shurshalina, A.; Fellous, M. M.; Nogai, H.; Xu, R. H.; Laetsch, T. W.; Drilon, A. E.
Abstract Title: Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120601282
DOI: 10.1200/JCO.2021.39.15_suppl.3108
PROVIDER: wos
Notes: Meeting Abstract: 3108 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon